209 related articles for article (PubMed ID: 15056846)
21. Down-regulation of VEGF mRNA expression by 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) antisense oligonucleotides and investigation of non-target gene expression.
Morita K; Yamate K; Kurakata S; Abe K; Imanishi T; Koizumi M
Nucleic Acids Res Suppl; 2002; (2):99-100. PubMed ID: 12903124
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and properties of 3'-amino-2',4'-BNA, a bridged nucleic acid with a N3'-->P5' phosphoramidate linkage.
Obika S; Rahman SM; Song B; Onoda M; Koizumi M; Morita K; Imanishi T
Bioorg Med Chem; 2008 Oct; 16(20):9230-7. PubMed ID: 18812260
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, duplex-forming ability, enzymatic stability, and in vitro antisense potency of oligonucleotides including 2'-C,4'-C-ethyleneoxy-bridged thymidine derivatives.
Osawa T; Sawamura M; Wada F; Yamamoto T; Obika S; Hari Y
Org Biomol Chem; 2017 May; 15(18):3955-3963. PubMed ID: 28440828
[TBL] [Abstract][Full Text] [Related]
24. An improved synthesis of 2'-
Takagi-Sato M; Morita K; Onishi Y; Watahiki Y; Ishigaki T; Akita T; Tomita E; Kawakami J; Koizumi M
Nucleosides Nucleotides Nucleic Acids; 2020; 39(6):838-852. PubMed ID: 31997701
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the Knockdown Activity of MALAT1 ENA Gapmers In Vitro.
Iwashita S; Shoji T; Koizumi M
Methods Mol Biol; 2020; 2176():155-161. PubMed ID: 32865789
[TBL] [Abstract][Full Text] [Related]
26. Thioamide-Bridged Nucleic Acid (thioAmNA) Containing Thymine or 2-Thiothymine: Duplex-Forming Ability, Base Discrimination, and Enzymatic Stability.
Habuchi T; Yamaguchi T; Obika S
Chembiochem; 2019 Apr; 20(8):1060-1067. PubMed ID: 30552742
[TBL] [Abstract][Full Text] [Related]
27. Sulfonamide-bridged nucleic acid: synthesis, high RNA selective hybridization, and high nuclease resistance.
Mitsuoka Y; Fujimura Y; Waki R; Kugimiya A; Yamamoto T; Hari Y; Obika S
Org Lett; 2014 Nov; 16(21):5640-3. PubMed ID: 25341881
[TBL] [Abstract][Full Text] [Related]
28. True antisense oligonucleotides with modified nucleotides restricted in the N-conformation.
Koizumi M
Curr Top Med Chem; 2007; 7(7):661-5. PubMed ID: 17430207
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and properties of a novel bridged nucleic acid analogue, 5'-amino-3',5'-BNA.
Sekiguchi M; Obika S; Somjing R; Imanishi T
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1097-100. PubMed ID: 16248099
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and properties of 2',4'-BNA(NC): a bridged nucleic acid analogue.
Rahman SM; Seki S; Obika S; Yoshikawa H; Miyashita K; Imanishi T
J Am Chem Soc; 2008 Apr; 130(14):4886-96. PubMed ID: 18341342
[TBL] [Abstract][Full Text] [Related]
31. 'Ethylene-bis[phosphonate] nucleic acids': novel monomeric synthons for the solid-phase synthesis of (P-CH2-CH2-P)-bridged oligonucleotides.
Farschtschi N
Chem Biodivers; 2004 Mar; 1(3):402-14. PubMed ID: 17191855
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl] modified nucleosides and oligonucleotides.
Prakash TP; Kawasaki AM; Fraser AS; Vasquez G; Manoharan M
J Org Chem; 2002 Jan; 67(2):357-69. PubMed ID: 11798305
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 2',4'-BNACOC bearing a purine nucleobase.
Mitsuoka Y; Ohnishi R; Hari Y; Obika S; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2006; (50):13-4. PubMed ID: 17150793
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J
Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072
[TBL] [Abstract][Full Text] [Related]
35. Bridged Nucleic Acids Reloaded.
Soler-Bistué A; Zorreguieta A; Tolmasky ME
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234313
[TBL] [Abstract][Full Text] [Related]
36. 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) for effective antisense formation.
Morita K; Yamate K; Kurakata S; Watanabe K; Imanishi T; Koizumi M
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1619-21. PubMed ID: 14565480
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and properties of a novel 2',4'-BNA bearing a urea bridged structure.
Yahara A; Nishida M; Baba T; Kodama T; Imanishi T; Obika S
Nucleic Acids Symp Ser (Oxf); 2009; (53):11-2. PubMed ID: 19749235
[TBL] [Abstract][Full Text] [Related]
38. Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment.
Da Ros T; Spalluto G; Prato M; Saison-Behmoaras T; Boutorine A; Cacciari B
Curr Med Chem; 2005; 12(1):71-88. PubMed ID: 15638731
[TBL] [Abstract][Full Text] [Related]
39. [Design, syntheses and properties of nucleic Acid switch in response to external stimuli].
Kodama T
Yakugaku Zasshi; 2011 Jan; 131(1):101-11. PubMed ID: 21212620
[TBL] [Abstract][Full Text] [Related]
40. In vivo antisense activity of ENA oligonucleotides targeting PTP1B mRNA in comparison of that of 2'-MOE-modified oligonucleotides.
Koizumi M; Takagi-Sato M; Okuyama R; Araki K; Sun W; Nakai D
Nucleic Acids Symp Ser (Oxf); 2007; (51):111-2. PubMed ID: 18029611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
